2019
16 to 18 July
The University of Queensland
Protein Australia 2019
Protein Australia 2019 brought together scientists from academia and industry to contribute to the development of protein science and protein technology.
This national scientific meeting highlighted the recent advances on protein research, with a focus on protein engineering and production for structural and functional study and as protein-based bioproducts. The themes included protein engineering and production, protein quality and characterisation, and bioprocess innovation for biomanufacturing.
Photos from Protein Australia 2019
Dates and venue
Protein Australia 2019 was held 16 to 18 July 2019.
The venue was the Queensland Bioscience Precinct Auditorium at The University of Queensland, St Lucia, Australia
Testimonials
“Protein Australia was an outstanding experience..."
"I'd like to thank you and the PEF team for putting together a stunning conference...."
Sign up for updates
Want to know when the next Protein Australia is?
Register your interest for attending the next conference
Plenary Speakers
Fiona M. Wood, FRACS AM
Burns Surgeon and Clinical Professor
Ongoing quest to make a difference to people's lives
"The role of the Interdisciplinary Team in Translational Research"
Manon M. J. Cox, PhD MBA
CEO and Vaccine Technology Innovator
Driving change in the vaccine industry
"A blueprint for successful product development"
Special Lecture on Wildlife Conservation
Presented by Craig Franklin, Deputy Head of School & Professor School of Biological Sciences at The University of Queensland.
Titled: "Why biodiversity is important - insights from extreme life: an Australian perspective".
Followed by an interactive wildlife display.
Speakers
Ines I. Atmosukarto
Managing Director and Chief Scientific Officer
Lipotek Pty Ltd
"LipoChel liposomes, a versatile multivalent anchoring platform for recombinant proteins, with applications in flow cytometry and in vivo bio-imaging techniques"
Kym Baker
General Manager
Patheon, part of Thermo Fisher Scientific, Patheon Biologics Australia Pty Ltd
"Manufacturing modern miracles"
Megan Baldwin
CEO & Managing Director
Opthea Ltd
"OPT-302: A novel VEGF-C/D ‘Trap’ to Combat Retinal Eye Disease"
Jagan Billakanti
Senior BioProcess Scientist
Luina Bio
"Bacterial and yeast recombinant protein production – An industrial perspective"
Keith Chappell
Senior Research Fellow
The University of Queensland
"Rapid response pipeline for stabilised subunit vaccines"
Henry Chiou
Director of Product Management, Protein Expression & Transfection
Thermo Fisher Scientific
"Streamlining biologics development with the Expi systems"
David Craik
ARC Laureate Fellow
The University of Queensland
"Natural peptide-based scaffolds in drug design"
Craig Franklin
Deputy Head of School & Professor School of Biological Sciences
The University of Queensland
"Why biodiversity is important - insights from extreme life: an Australian perspective"
Gaurav Gupta
Senior Research Scientist
University of Oxford
"VLPs as carrier for potential vaccine candidates"
Brad Johnson
Director of Downstream Process Development
Thermo Fisher Scientific
"Using innovation to tackle the downstream process bottleneck"
Catherine Owczarek
Director, Recombinant Proteins
CSL Limited
"Recombinant Protein Expression in Mammalian Cells: Bridging the gap between research and development"
Bernd Rehm
Professor and Director of Centre for Cell Factories and Biopolymers
Griffith University
"In vivo assembled polyester scaffolds for protein production"
Derek Richard
Professor and Scientific Director of Cancer & Ageing Research Program
Queensland University of Technology
"Understanding the role of DNA repair in disease and ageing"
Anne Skaja Robinson
Professor and Head of Chemical Engineering
Carnegie Mellon University
"Control of glycosylation in antibody expression in CHO cells"
Sabine Suppmann
Head Protein Production
Max Planck Institute of Biochemistry
"A Protein Production Core Facility - the Good, the Bad and the Ugly"
Nicole van der Weerden
CEO
Hexima Limited
"Using natures antimicrobial peptide arsenal to treat fungal nail infections"
Ross Wilson
Principal Investigator
Berkeley University of California
"Engineering CRISPR-Cas9 for cell-targeted therapeutic genome editing"
Highlights
Sponsors
Contact
Sponsorship
Updates
Sign up for our mailing list to get notified when registration opens